Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Other Non-Current Assets (2015 - 2025)

Sol-Gel Technologies (SLGL) posted quarterly Other Non-Current Assets of $62000.0 for Q4 2025, down 94.73% year-over-year from $1.2 million in Q4 2024, and down 94.76% quarter-over-quarter from $1.2 million in Q2 2025.

Analysis

Sol-Gel Technologies (SLGL) Other Non-Current Assets (2015 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Other Non-Current Assets for 8 consecutive years, with $62000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Non-Current Assets fell 94.73% year-over-year to $62000.0; the TTM figure through Dec 2025 stood at $62000.0 (down 94.73% YoY), while the FY2025 annual figure was $62000.0, down 94.73% from the prior year.
  • Other Non-Current Assets declined to $62000.0 in Q4 2025 per SLGL's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.0 million in Q1 2023 and bottomed at $45000.0 in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.2 million in 2021.
  • On a YoY basis, Other Non-Current Assets climbed as much as 236.0% in 2024 and fell as far as 99.1% in 2024.
  • Sol-Gel Technologies' Other Non-Current Assets stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then tumbled by 69.57% to $350000.0 in 2023, then soared by 236.0% to $1.2 million in 2024, then sank by 94.73% to $62000.0 in 2025.
  • Business Quant data shows SLGL's Other Non-Current Assets at $62000.0 in Q4 2025, $1.2 million in Q2 2025, and $1.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 62,000.00
Jun 30, 2025 1.18 Mn
Dec 31, 2024 13,000.00
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 45,000.00
Dec 31, 2023 350,000.00
Jun 30, 2023 1.17 Mn
Dec 31, 2022 1.15 Mn
Jun 30, 2022 1.15 Mn
Dec 31, 2021 1.15 Mn
Jun 30, 2021 1.15 Mn
Dec 31, 2020 1.15 Mn
Jun 30, 2020 1.15 Mn
Dec 31, 2019 350,000.00
Jun 30, 2019 350,000.00
Dec 31, 2018 350,000.00
Jun 30, 2018 350,000.00
Dec 31, 2016 9,000.00
Dec 31, 2015 89,000.00